Trials / Unknown
UnknownNCT02126904
Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
Comparison of the Time to Recurrence After Ranibizumab or Aflibercept Loading for Age-related Macular Degeneration
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Yokohama City University Medical Center · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The investigators compared the time to recurrence after ranibizumab or aflibercept loading in patients with AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IVA group |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-10-01
- First posted
- 2014-04-30
- Last updated
- 2014-04-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02126904. Inclusion in this directory is not an endorsement.